In addition, given the profound decrease in ADAMTS13 levels and specific activity, we surmise the existence of backup mechanisms to control VWF reactivity in patients with acute liver failure and advanced chronic liver disease as we and others previously proposed [11,37]. The gene discussed is ADAMTS13; the disease is acute liver failure.